Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats

L. Vécsei, Ibolya Bollók, G. Telegdy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

In the present study the effect of intracerebroventricularly (ICV) administered somatostatin on electroconvulsive shock- (ECS) induced retrograde amnesia was investigated in rats. The ECS significantly decreased foot shock-induced avoidance latency. Somatostatin in a dose of 1 μg 4 μl (ICV) had no action on the ECS-induced retrograde amnesia, while in a dose of 4 μg 4 μl it significantly increased the avoidance latency if the treatment was performed immediately, 4 hr, 20 hr or 23 hr after the ECS. The results suggest that ICV administered somatostatin has an antiamnesic effect.

Original languageEnglish
Pages (from-to)293-295
Number of pages3
JournalPeptides
Volume4
Issue number3
DOIs
Publication statusPublished - 1983

Fingerprint

Electroshock
Amnesia
Somatostatin
Rats
Retrograde Amnesia
Foot
Shock

Keywords

  • Amnesia
  • Electroconvulsive shock
  • Passive avoidance
  • Rats
  • Somatostatin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats. / Vécsei, L.; Bollók, Ibolya; Telegdy, G.

In: Peptides, Vol. 4, No. 3, 1983, p. 293-295.

Research output: Contribution to journalArticle

@article{6f4076622912431a9c794a1a5ae28444,
title = "Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats",
abstract = "In the present study the effect of intracerebroventricularly (ICV) administered somatostatin on electroconvulsive shock- (ECS) induced retrograde amnesia was investigated in rats. The ECS significantly decreased foot shock-induced avoidance latency. Somatostatin in a dose of 1 μg 4 μl (ICV) had no action on the ECS-induced retrograde amnesia, while in a dose of 4 μg 4 μl it significantly increased the avoidance latency if the treatment was performed immediately, 4 hr, 20 hr or 23 hr after the ECS. The results suggest that ICV administered somatostatin has an antiamnesic effect.",
keywords = "Amnesia, Electroconvulsive shock, Passive avoidance, Rats, Somatostatin",
author = "L. V{\'e}csei and Ibolya Boll{\'o}k and G. Telegdy",
year = "1983",
doi = "10.1016/0196-9781(83)90135-3",
language = "English",
volume = "4",
pages = "293--295",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats

AU - Vécsei, L.

AU - Bollók, Ibolya

AU - Telegdy, G.

PY - 1983

Y1 - 1983

N2 - In the present study the effect of intracerebroventricularly (ICV) administered somatostatin on electroconvulsive shock- (ECS) induced retrograde amnesia was investigated in rats. The ECS significantly decreased foot shock-induced avoidance latency. Somatostatin in a dose of 1 μg 4 μl (ICV) had no action on the ECS-induced retrograde amnesia, while in a dose of 4 μg 4 μl it significantly increased the avoidance latency if the treatment was performed immediately, 4 hr, 20 hr or 23 hr after the ECS. The results suggest that ICV administered somatostatin has an antiamnesic effect.

AB - In the present study the effect of intracerebroventricularly (ICV) administered somatostatin on electroconvulsive shock- (ECS) induced retrograde amnesia was investigated in rats. The ECS significantly decreased foot shock-induced avoidance latency. Somatostatin in a dose of 1 μg 4 μl (ICV) had no action on the ECS-induced retrograde amnesia, while in a dose of 4 μg 4 μl it significantly increased the avoidance latency if the treatment was performed immediately, 4 hr, 20 hr or 23 hr after the ECS. The results suggest that ICV administered somatostatin has an antiamnesic effect.

KW - Amnesia

KW - Electroconvulsive shock

KW - Passive avoidance

KW - Rats

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0020514703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020514703&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(83)90135-3

DO - 10.1016/0196-9781(83)90135-3

M3 - Article

C2 - 6138755

AN - SCOPUS:0020514703

VL - 4

SP - 293

EP - 295

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -